Diabetes Education

Top Story

In diabetes device era, parents still report substantial type 1 burden

August 17, 2017

Despite the availability of advanced diabetes technology, parents of young children with type 1 diabetes continue to report substantial burdens and negative family impact stemming from the disease, according to findings published in the Journal of Diabetes Science and Technology.

“Diabetes technologies have improved substantially in the past several decades, with tools such as smart insulin pumps with bolus calculators and continuous glucose monitors,” Kara R. Harrington, PhD, a clinical and research fellow with the Joslin Diabetes Center in Boston, and colleagues wrote. “Along with these technical advancements come new challenges and possible burdens, especially for young children and their families. ... Thus, it is important to ascertain typical burdens and stresses of parents of young children with diabetes in the contemporary diabetes management era. It is also important to understand how the burdens reported by parents are impacted by use or nonuse of different diabetes technologies, as well as by other demographic factors, such as socioeconomic status.”

In the Journals Plus

Self-compassion improves psychological well-being, self-management in diabetes

August 16, 2017
In adults with type 1 and type 2 diabetes, a high level of self-compassion predicts a higher psychological well-being and is a predicter for several diabetes…
Meeting News

In transition from hospital to home, diabetes educators can take the lead

August 8, 2017
INDIANAPOLIS — Patients with diabetes seeking acute medical care today are sicker, frailer and have more complex medical conditions and treatment plans…
In the Journals Plus

Online diabetes self-management game helps patients improve HbA1c

August 8, 2017
Veterans with type 2 diabetes saw significant improvements in HbA1c after participation in a 6-month diabetes self-management education game compared with patients who…
More Headlines »

Improving Outcomes with SGLT2 Cotransporter Inhibitors in Challenging T2DM Patients - Monograph

This activity is supported by an educational grant from Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC

Recent advances with novel orally administered SGLT2 cotransporter inhibitors, a new class of antidiabetes agents that…
More »
Meeting News

VIDEO: Snowboarder’s camps empower kids with type 1 diabetes

August 5, 2017
More »
Resource Centers

Diabetic Retinopathy: Preferred Practice Patterns in Screening and Management

This activity is supported by an educational grant from Regeneron.

Diabetic retinopathy (DR) is a major cause of blindness among American adults aged 40 years and older. The prevalence…
More »